Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference

NEW BRUNSWICK, N.J., Sept. 6, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley Global Health Care Conference Tuesday, September 13th, at the Grand Hyatt New York, 109 East 42nd Street at Grand Central, New York, NY.  Dominic Caruso, Vice President, Finance and Chief Financial Officer, Executive Committee for Johnson & Johnson, will represent the company in a session scheduled at 10:20 a.m. (Eastern).

This broadcast will be available to interested investors and parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available shortly after the live webcast.

SOURCE Johnson & Johnson

Suggested Articles

An oncologist leader RBC Capital Markets interviewed expressed comfort that Trodelvy will succeed in earlier-line TNBC and in HR-positive disease.

Gilead Sciences is the latest drugmaker to settle Justice Department claims that its charity contributions were actually kickbacks.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.